Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A.

In conclusion, this study found that uncarboxylated osteocalcin alleviates NAFLD in mice through the GPRC6A signaling pathway. Our study suggests that liver GPRC6A may be a potential target for treating NAFLD. PMID: 33531899 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/33531899?dopt=Abstract

Source: International Journal of Endocrinology - February 4, 2021 Category: Endocrinology Tags: Int J Endocrinol Source Type: research